ACS Clinical Research Program rss

dispatches-table

Multimodality treatment considerations in esophageal and gastric cancer: Are we making progress?(Comments Off)

July 1, 2015

This column addresses the efficacy of combining existing approaches with active therapeutic combinations to treat cancers of the stomach and esophagus.

OperativeStandardsCover

New manual for cancer surgery issued: Operative Standards for Cancer Surgery

Operative Standards for Cancer Surgery, developed by the ACS Clinical Research Program Cancer Care Standards Development Committee, provides evidence-based guidelines for oncologic resections.

Alliance for Clinical Trials in Oncology

Limited resection as a cure for early lung cancer: Time to challenge the gold standard?

A clinical trial is exploring whether limited resection should replace lobectomy as the gold standard for treatment of early-stage lung cancer.

clinical-res-fig1

Progress in the PROSPECT trial: Precision treatment for rectal cancer?

The PROSPECT trial for individualized treatment is discussed in this month’s column as is the surgeon’s role in ensuring the success of this trial.

Figures 1A, 1B, 1C, 1D

Colorectal cancer metastatic to the liver: Making the unresectable resectable

Advances in the treatment of metastatic colorectal cancer have led to greatly improved survival rates, especially for patients with liver-only disease. These new approaches have increased the role of surgeons in the management of these patients.


More in this category

« Older Posts   

Contact

Bulletin of the American College of Surgeons
633 N. Saint Clair St.
Chicago, IL 60611